4,848 followers
New Research: Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy: Background Immunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of… https://t.co/CMH8lHo8